|
Clinicians, n
|
112
|
55
|
70
|
90
|
87
|
|
Nurse practitioners, n (%)*
|
19 (17)
|
6 (11)
|
8 (11)
|
12 (13)
|
15 (17)
|
|
Female, n (%)
|
71 (63)
|
32 (58)
|
44 (63)
|
56 (62)
|
54 (62)
|
|
Attested for meaningful use, n (%)†
|
42 (38)
|
33 (60)
|
42 (60)
|
42 (47)
|
41 (47)
|
|
Annual patients per clinician, median (Q1-Q3)
|
791 (406-1269)
|
968 (424-1336)
|
896 (429-1341)
|
758 (354-1337)
|
521 (391-794)
|
|
Annual encounters per clinician, median (Q1-Q3)
|
1357 (630-2287)
|
1850 (840-2416)
|
1695 (834-2562)
|
1580 (508-2389)
|
882 (511-1277)
|
|
Patient comorbidity score, median (Q1-Q3)‡
|
0.3 (0.2-0.4)
|
0.3 (0.2-0.4)
|
0.3 (0.2-0.4)
|
0.4 (0.2-0.5)
|
0.3 (0.2-0.4)
|
|
BPAs in use, total
|
126
|
93
|
94
|
98
|
93
|
|
Annual BPAs received per clinician, median (Q1-Q3)
|
4227 (2057-6897)
|
5265 (2739-7652)
|
5075 (2602-8070)
|
4310 (1756-7249)
|
2486 (1625-3799)
|
|
Percent BPAs accepted per clinician, median (Q1-Q3)
|
19.4 (11.8-28.5)
|
18.6 (13.0-27.0)
|
19.6 (12.6-30.0)
|
20.9 (10.7-30.0)
|
18.6 (10.4-26.0)
|
|
DDI/DAI alerts in use, total
|
3213
|
2045
|
1599
|
1819
|
1364
|
|
Annual alerts received per clinician, median (Q1-Q3)
|
966 (407-1762)
|
1116 (580-2169)
|
1140 (547-2131)
|
1231 (310-1831)
|
622 (255-969)
|
|
Percent accepted per clinician, median (Q1-Q3)
|
0.0 (0.0-0.3)
|
0.0 (0.0-0.4)
|
0.0 (0.0-0.4)
|
0.0 (0.0-0.2)
|
0.0 (0.0-0.2)
|
